A significant reduction in CHRNA1 expression was also observed in MG thymomas, particularly in thymomas from corticosteroid-naïve patients, compared to non-MG thymomas and control thymuses (Figure 1a,c). This evidence concerns the gene CHRNA1 and myasthenia gravis.